Teva Pharma (TEVA) PT Raised to $15 at Cantor Fitzgerald
Tweet Send to a Friend
Cantor Fitzgerald analyst Louise Chen raised the price target on Teva Pharma (NYSE: TEVA) to $15.00 (from $9.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
